Mode
Text Size
Log in / Sign up
N/A Completed N=99 Randomized Single-blind Treatment

Anterior Colporrhaphy Versus Cystocele Repair Using Polypropylene Mesh or Porcine Dermis

Anterior Vaginal Wall Prolapse · Cystocele · pelvic organ prolapse
Source: ClinicalTrials.gov NCT01393171 ↗
Enrolled (actual)
99
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Prospective Randomized Trial of Anterior Colporrhaphy Vs. Cystocele Repair Using Polypropylene Mesh or Porcine Dermis — 5; 14; 12 Participants

Summary

The purpose of this study is to evaluate the success rate of cystocele repair using polypropylene mesh or porcine dermis compared to that of anterior colporrhaphy in a prospective randomized fashion. The study will be performed in a randomized, prospective, single-blinded fashion.

Outcome Measures

OutcomeResultp-value
PRIMARY
Prospective Randomized Trial of Anterior Colporrhaphy Vs. Cystocele Repair Using Polypropylene Mesh or Porcine Dermis
5; 14; 12
SECONDARY
Number of Participants With One or More Adverse Events at Two Years
7; 4; 5
SECONDARY
Number of Participants With Overall Failure
1; 3; 3
SECONDARY
Change in Quality of Life Measured by the Pelvic Floor Distress Inventory 20 and Pelvic Floor Impact Questionnaire 7
-63; -58; -77; -57; -33; -55
SECONDARY
Change in Postoperative Sexual Function Measured by Pelvic Organ Prolapse/Urinary Incontinence Questionnaire 12
0; 0; 1

Eligibility Criteria

Inclusion Criteria

  • Stage 2 or > anterior vaginal prolapse requiring surgical correction.
  • >18 years old
  • willing to return for follow-up visits.

Exclusion Criteria

  • Less than stage II or > anterior vaginal prolapse,
  • decline to participate,
  • pregnant or contemplating future pregnancy,
  • anti-incontinence procedure other than midurethral sling (ie, Burch colposuspension, pubovaginal sling, or needle suspension) is planned as part of their surgical procedures,
  • any contra-indication to receiving mesh or porcine dermis.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01393171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search